Children with autism may see speech improvement with off-label prescription medication
Off-label prescription medication has been shown to help some autistic nonverbal children discover their ability to speak.
New York pharmacist Katy Dubinsky said the drug is a prescription vitamin similar to folic acid that helps restore folic acid levels in patients who may be difficult to absorb or use it. , a private supplement company.
“White cells have approved FDA approval to reduce the toxic effects of methotrexate in cancer treatment and to prevent or treat certain anemia caused by folic acid deficiency,” Dubinsky told Fox News Digital.
Is the MMR vaccine safe for children? Dr. Nicole Saphier solves the problem of measles cases
Experts say that while there is no nucleoprotein for autism treatment, some families have found that their off-label use has led to a significant improvement in communication skills in children with autism.
Richard E. Frye, MD, MD, PhD, Behavioral Pediatric Neurology in Arizona, studied the drug in an experimental treatment study in children with autism spectrum disorder.
Off-label prescription medication has been shown to help some autistic nonverbal children discover their ability to speak. (iStock)
He told Fox News Digital Digital: “Lycium is a special form of vitamin B9.
“For years, folic acid has been found to be safe for a long time, which is why we use folic acid to supplement our food.”
Bill Gates, who may have had autism as a child, revealed: “No broad understanding”
Fry said the main benefit of leucovorin for children with autism is language improvement, but other advantages may include enhanced social functioning, reduced repetitive behaviors and stronger attention skills.
“Our goal is to get FDA-approved leucovorin for autism to be widely prescribed as the first treatment after diagnosis.”
“We did find that Medokolin helps a large number of children with autism,” he said. “Language is one of the most obvious things, so that’s what we measured in clinical trials.”
Dr. Marc Siegel, senior medical analyst at NYU Langone Health and Fox News, also talked with Fox News Digital about why the drug may have a positive impact.
Although there is no xyloprotein for autism treatment, some families have found that the amount of their label has led to a significant improvement in communication skills in children with autism. (iStock)
“The lack of folate centers is a lack of folate in the brain, which may interfere with neurological function,” he said. “It has been found that a large percentage of children with autism spectrum disorder have antibodies to the lobe receptor alpha in the brain.”
Siegel said white blood cells are converted into folic acid in the brain through different pathways.
“Small studies show that it improves neurological function and communication skills in children with ASD, but requires large studies.”
Experts urge caution
According to doctors, the fact that leucovorin has been used for a long time helps reduce the associated risks.
“One of the advantages of using leukocyte protein is that it has been used to protect the body from chemotherapy, so we know what dose to use and any side effects that may have,” Frye told Fox News Digital Digital.
New research suggests that the risk of autism may increase with air pollution.
However, some children do become “extremely active” and do not respond to leucorrhea and ultimately need alternative treatments.
He suggests that it is important for families to work with medical professionals when exploring the use of megoxin for autism.
According to pharmacists, the drug leukocytopenia is a prescription vitamin that works similarly to folic acid and helps restore folic acid levels in patients who may be difficult to absorb or use it. (iStock)
“The dose of white calories is much higher than conventional vitamins, so it’s very important to work with a doctor on how to prescribe it,” Fry said.
“It is important to test patients for abnormalities in the folic acid pathway, such as folate receptor autoantibodies, so we know they are candidates for this drug.”
Click here to get the Fox News app
Although there are lobular cords in the pharmacy, Fry notes that some children need a composite form because they are sensitive to certain additives in commercial products.
“Our goal is to get FDA-approved leucovorin for autism, so once diagnosed it can be widely prescribed as the earliest treatment,” he said.
Frye notes that autism does not have “magic bullets” and many children benefit from the combination of multiple therapies. (iStock)
Dobinsky agreed that doctors could prescribe “widely used and well-tolerated drugs” for autism treatment based on their “clinical judgment and emerging evidence,” but she also emphasized the importance of clinical trials.
“While doctors can now prescribe Medokolon, FDA approval will provide stronger medical support, making it a recognized treatment, not just an off-label option,” she told Fox News Digital.
Click here to sign up for our health newsletter
“This could lead to insurance coverage, standardized dosing guidelines and wider acceptance in the medical community.”
Siegel added that Leucovorin is a “safe drug” and should be considered for large-scale use based on recent research results.
“No magic bullets”
Frye notes that autism does not have “magic bullets” and many children benefit from the combination of multiple therapies.
“Menuclein cannot be used alone – it must be used with behavioral and speech therapy,” he said. “We believe that Megoxin can improve the prognosis of these therapies.”
“There is little evidence that the benefits observed in this case can be generalized to the wider autistic community.”
Andy Shih, chief science officer who spoke in New York, said that every child’s experience of autism is unique.
“There is little evidence that the benefits observed in this case can be generalized to the wider autism community,” he told Fox News Digital.
For more health articles, please visit www.foxnews.com/health
“Although some small studies have explored white leaf protein as a potential treatment for patients with autism, larger controlled clinical trials are needed to determine their efficacy and safety. We urge families to consult with their doctors before considering non-label treatments. .”
If larger studies confirm the effectiveness of medocono protein, it could be a more accessible treatment for children with autism who may benefit from it. .
